市場調查報告書
商品編碼
1542416
全球血液氣體和電解質分析儀市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測Global Blood Gas and Electrolyte Analyzers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球血氣和電解質分析儀市場需求預計將從 2023 年的 33.5 億美元達到近 52.5 億美元的市場規模,2024-2032 年研究期間複合年成長率為 5.12%。
血氣和電解質分析儀用於測量全血樣本中的血氣、電解質、pH 值和特定代謝物。血液氣體和電解質分析儀評估實際血液樣本的各種特徵,包括動脈氣體,如氧氣 (pO2)、二氧化碳 (pCO2)、pH、電解質和代謝物。對於血氣、離子鈣、酸鹼平衡、電解質、BUN、葡萄糖和乳酸,可提供快速、精確的結果。血氣和電解質分析儀採用創新的現代技術。電極用於血氣分析儀,而離子選擇電極 (ISE) 技術用於電解質分析儀。血氣和電解質分析儀可提供實驗室品質的讀數,無需額外的待機成本。它們還具有較寬的工作溫度範圍,可滿足寒冷氣候的需求。它也只需要很少的維護。
慢性病盛行率增加,全球老年人口增加,ICU、新生兒重症監護室和急診室治療的患者人數增加,血氣和電解質分析儀技術進步以及產品數量增加全球的批准都在推動血氣和電解質分析儀市場的發展。對血液氣體和電解質分析儀的需求因分析儀的高成本和解釋血液分析資料的複雜性而受到阻礙。此外,血氣分析儀與電子病歷和實驗室資訊系統的整合呈現出巨大的市場拓展前景。此外,在預測期內,對技術整合組合系統和照護端設備的需求可能會顯著推動市場。此外,各種攜帶式、桌上型、易於使用、精度更高和快速的設備的出現,以及政府的各種舉措和策略,以及主要市場參與者在提高診斷意識方面的關鍵作用,都有助於提高診斷意識。全球醫療保健支出的大幅增加進一步推動了市場的發展。人口(尤其是老年人)的成長以及醫療服務使用的增加是推高醫療保健成本的兩個根本原因。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球血氣和電解質分析儀市場的各個細分市場進行了包容性評估。血氣和電解質分析儀行業的成長和趨勢為這項研究提供了整體方法。
血氣和電解質分析儀市場報告的這一部分提供了國家和區域級別細分市場的詳細資料,從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的血氣和電解質分析儀市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。血液氣體和電解質分析儀市場的主要參與者包括 Abbott、梅州康利高科技有限公司、Radiometer Medical ApS、EDAN Instruments Inc.、Erba Mannheim、F. Hoffmann-La Roche Ltd、Fortress Diagnostics、Werfen 等。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Blood Gas and Electrolyte Analyzers Market is presumed to reach the market size of nearly USD 5.25 Billion by 2032 from USD 3.35 Billion in 2023 with a CAGR of 5.12% under the study period 2024-2032.
A blood gas and electrolyte analyzer is used to measure blood gas, electrolytes, pH, and specific metabolites in whole blood specimens. Blood gas and electrolyte analyzers evaluate various characteristics from actual blood samples, including arterial gases like oxygen (pO2), carbon dioxide (pCO2), pH, electrolytes, and metabolites. For blood gases, ionized calcium, acid-base balance, electrolytes, BUN, glucose, and lactate deliver speedy and precise findings. Innovative and modern technology is used in blood gas and electrolyte analyzers. Electrodes are used in blood gas analyzers, whereas ion-selective electrode (ISE) technology is used in electrolyte analyzers. Blood Gas and Electrolyte Analyzers give lab-quality readings with no additional costs for standby. They also have a wide operating temperature range to accommodate the needs of colder climates. It also takes very little upkeep.
An increase in the prevalence of chronic disorders, an increase in the global geriatric population, rise in the number of patients treated in ICUs, NICUs, and emergency departments, technological advancements in blood gas and electrolyte analyzers, and an increase in the number of product approvals globally are all driving the market for blood gas and electrolyte analyzers. The need for blood gas and electrolyte analyzers is hampered by the high cost of analyzers and the complexity of interpreting blood analysis data. Furthermore, the integration of blood gas analyzers with electronic medical records and laboratory information systems presents a significant market expansion prospect. Furthermore, during the forecast period, the need for technology-integrated combined systems and point-of-care devices is likely to drive the market significantly. Moreover, the availability of various portable, benchtop, easy to use, with higher accuracy and rapid devices, as well as the government's various initiatives and strategies, as well as key market players' pivotal roles in raising awareness for diagnosis, all contribute to the blood gas and electrolyte analyzers market's growth. The market has been fueled even more by a significant increase in global healthcare spending. The rise in population, particularly among the elderly, and the increased use of medical services are the two fundamental reasons driving up healthcare costs.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Blood Gas and Electrolyte Analyzers. The growth and trends of Blood Gas and Electrolyte Analyzers industry provide a holistic approach to this study.
This section of the Blood Gas and Electrolyte Analyzers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Blood Gas and Electrolyte Analyzers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Blood Gas and Electrolyte Analyzers market include Abbott, Meizhou Cornley High-Tech Co. Ltd., Radiometer Medical ApS, EDAN Instruments Inc., Erba Mannheim, F. Hoffmann-La Roche Ltd, Fortress Diagnostics, Werfen, . This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.